Picolinic acid, a catabolite of tryptophan, has an anabolic effect on bone in vivo

Gustavo Duque*, Christopher Vidal, Wei Li, Ahmed Al Saedi, Mamdouh Khalil, Chai K. Lim, Damian E. Myers, Gilles J. Guillemin

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Fractures attributable to osteoporosis have a severe impact on our older population. Reports of side effects with commonly prescribed osteoporosis drugs have led to the investigation of new and safer treatments with novel mechanisms of action. Picolinic acid (PIC), a catabolite of tryptophan, induces in vitro osteogenic differentiation of mesenchymal stem cells. Here we demonstrate that PIC has an anabolic effect on bone in vivo by increasing bone formation, bone mass, and bone strength in normal and ovariectomized C57BL/6 mice. Activation of the osteogenic pathways triggered this osteoanabolic response without any cross-related effects on mineral absorption or calciotropic hormones. Because PIC was also well tolerated and absorbed with no side effects, it is an ideal potential candidate for the treatment of osteoporosis.

Original languageEnglish
Pages (from-to)2275-2288
Number of pages14
JournalJournal of Bone and Mineral Research
Volume35
Issue number11
Early online date6 Jul 2020
DOIs
Publication statusPublished - Nov 2020

Keywords

  • Kynurenine
  • Osteoanabolics
  • Osteoblasts
  • Osteoporosis
  • Picolinic acid
  • WNT

Fingerprint Dive into the research topics of 'Picolinic acid, a catabolite of tryptophan, has an anabolic effect on bone in vivo'. Together they form a unique fingerprint.

Cite this